Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1998
06/18/1998WO1998025914A1 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate
06/18/1998WO1998025904A1 Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
06/18/1998WO1998025903A1 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
06/18/1998WO1998025901A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
06/18/1998WO1998025900A1 Compounds having antitumor activity
06/18/1998WO1998025899A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
06/18/1998WO1998025898A1 Seco precursors of cyclopropylindolines and their use as prodrugs
06/18/1998WO1998025895A1 Inhibitors of the enzymatic activity of psa
06/18/1998WO1998025892A1 Integrin antagonists
06/18/1998WO1998025887A2 Formulations and polymorphic forms of desferrioxamine and the preparation thereof
06/18/1998WO1998025883A1 Ketobenzamides as calpain inhibitors
06/18/1998WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
06/18/1998WO1998025649A1 Use of low molecular weight amino alcohols in ophthalmic compositions
06/18/1998WO1998025648A2 Use of a texaphyrin in ocular diagnosis and therapy
06/18/1998WO1998025640A2 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease
06/18/1998WO1998025639A1 HYPOGLYCEMIC AGENTS FROM HARUNGANA OR $i(VISMIA SPP.)
06/18/1998WO1998025632A1 Compositions and methods for enhancement of dehydroepiandrosterone
06/18/1998WO1998025631A1 Treatment of osteoarthritis by administering poly-n-acetyl-d-glucosamine
06/18/1998WO1998025629A1 Prophylactic and therapeutic agent for inflammatory intestinal diseases
06/18/1998WO1998025628A1 Pharmaceutical compositions containing alendronate and an agent promoting gastric emptying
06/18/1998WO1998025627A1 17α-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT
06/18/1998WO1998025626A1 Use of equilenin as an antioxidant
06/18/1998WO1998025625A1 USE OF 17β-DIHYDROEQUILENIN AS AN ANTIOXIDANT
06/18/1998WO1998025624A1 Remedy for axillary osmidrosis containing adrenocorticosteriodal preparation
06/18/1998WO1998025622A1 Methods and compositions for preventing and treating bone loss
06/18/1998WO1998025621A1 Improved pharmaceutical compositions
06/18/1998WO1998025620A1 Process for manufacturing ophthalmic suspensions
06/18/1998WO1998025619A1 Novel compounds
06/18/1998WO1998025618A1 Use of nucleosides, nucleobases, and their derivatives for reduction of toxic side effects of cytostatic agents
06/18/1998WO1998025617A1 Substituted aryl piperazines as modulators of chemokine receptor activity
06/18/1998WO1998025616A1 Leukotriene antagonists for cerebral focal stroke
06/18/1998WO1998025615A1 Leukotriene antagonists for oral squamous cell carcinoma
06/18/1998WO1998025614A1 Topical application of opioid analgesic drugs such as morphine
06/18/1998WO1998025613A2 Galenic composition containing opioid antagonists
06/18/1998WO1998025612A1 Novel therapeutic application of pyrrole derivatives
06/18/1998WO1998025611A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
06/18/1998WO1998025610A1 Use of green porphyrins for the manufacture of a medicament for the treatment of secondary cataracts
06/18/1998WO1998025609A1 PYRROLES AS sPLA2 INHIBITORS
06/18/1998WO1998025608A1 Pharmaceutical compositions comprising a 4-arylcoumarin for the treatment of viral infections
06/18/1998WO1998025607A1 Use of inhibitors of monoamine oxidase type a for treating seizure disorders
06/18/1998WO1998025606A1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
06/18/1998WO1998025605A1 Spiro-substituted azacycles as modulators of chemokine receptor activity
06/18/1998WO1998025604A1 Spiro-substituted azacycles as modulators of chemokine receptor activity
06/18/1998WO1998025603A1 Isomeric pharmaceutical formulation containing dfmo for the treatment of cancer
06/18/1998WO1998025602A1 Glaucoma remedy
06/18/1998WO1998025601A1 Fibrinogen receptor antagonists
06/18/1998WO1998025600A1 Leukotriene antagonists for treatment or inhibition of gout
06/18/1998WO1998025599A1 An oil composition of dihydropolyprenols
06/18/1998WO1998025598A2 Methods and pharmaceutical compositions for inhibiting tumour cell growth
06/18/1998WO1998025597A2 Method for treating and preventing heart failure and ventricular dilatation
06/18/1998WO1998025596A2 Use of a 6-aryl pyrimidine compound for treating multiple sclerosis
06/18/1998WO1998025595A2 Aqueous drink composition comprising ibuprofen
06/18/1998WO1998025594A2 Lamotrigine in the treatment and prophylaxis of migraine
06/18/1998WO1998025593A2 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kB FACTOR
06/18/1998WO1998025592A1 Transdermal preparation containing serotonin receptor antagonist
06/18/1998WO1998025591A1 Transdermal drug delivery system for the treatment of heart diseases
06/18/1998WO1998025589A1 Active agent transport systems
06/18/1998WO1998025588A1 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
06/18/1998WO1998025587A1 Use of lipophilic antioxidant compounds to prevent retinoid induced, uva-mediated oxidative reactions
06/18/1998WO1998025573A2 The use of celastrol to treat alzheimer's disease
06/18/1998WO1998025469A1 The use of cd4-binding small molecules to inhibit immune responses
06/18/1998WO1998025466A1 Compositions for the systemic control of parasites of warm-blooded animals
06/18/1998WO1998025460A1 Compositions and methods for stimulating bone growth
06/18/1998WO1998018477A3 Pharmaceutical compositions containing lamivudine and zidovudine
06/18/1998WO1998018430A3 P2y receptor antagonists
06/18/1998WO1998015568A3 Nitrate esters of corticoid compounds and pharmaceutical applications thereof
06/18/1998WO1998008956A3 Use of a mutated macrolide binding protein for the prevention of gvhd
06/18/1998DE19652268A1 Wirkstoffträger für die Freisetzung von Apomorphin in der Mundhöhle Drug carrier for release of apomorphine in the oral cavity
06/18/1998DE19652239A1 Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen Use of 7- (2-oxa-5,8-diazabicyclo [4.3.0] non-8-yl) -chinolon- -naphthyridoncarbonsäure and derivatives for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith
06/18/1998DE19652219A1 Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen Use of 7- (1-Aminomethyl-2-oxa-7-azabicyclo [3.3.0] oct-7-yl) -chinolon- and naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith
06/18/1998DE19652196A1 Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen Homogeneous steroid preformulations for producing low-dose solid and semi-solid pharmaceutical preparations
06/18/1998DE19652188A1 Flache Arzneizubereitung zur Applikation und Freisetzung von Buprenorphin oder einer pharmakologisch vergleichbaren Substanz in der Mundhöhle und Verfahren zu ihrer Herstellung Flat pharmaceutical preparation for application and release of buprenorphine or a pharmacologically similar substance in the oral cavity and processes for their preparation
06/18/1998DE19651681A1 Stabile, wäßrige Dispersionen und stabile, wasserdispergierbare Trockenpulver von Xanthopyllen, deren Herstellung und Verwendung Stable, aqueous dispersions and stable, water-dispersible dry powder of Xanthopyllen, their preparation and use
06/18/1998DE19651563A1 Verwendung von Hemmstoffen der Monoaminoxidase Typ A zur Behandlung von epileptischen Erkrankungen Use of inhibitors of monoamine oxidase type A for the treatment of epileptic disorders
06/18/1998DE19651551A1 Opioidantagonisthaltige galenische Formulierung Opioid antagonist-containing pharmaceutical formulation
06/18/1998CA2278937A1 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
06/18/1998CA2275340A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine
06/18/1998CA2274958A1 Inhibitors of the enzymatic activity of psa
06/18/1998CA2274908A1 Leukotriene antagonists for cerebral focal stroke
06/18/1998CA2274898A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
06/18/1998CA2274858A1 Novel treatment
06/18/1998CA2274855A1 Leukotriene antagonists for oral squamous cell carcinoma
06/18/1998CA2274839A1 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
06/18/1998CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
06/18/1998CA2274833A1 Epothilone analogs
06/18/1998CA2274789A1 Compositions and methods for stimulating bone growth
06/18/1998CA2274761A1 Formulations and polymorphic forms of desferrioxamine and the preparation thereof
06/18/1998CA2274682A1 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate
06/18/1998CA2274655A1 Novel compounds
06/18/1998CA2274604A1 The use of cd4-binding small molecules to inhibit immune responses
06/18/1998CA2274571A1 Pyrroles as spla2 inhibitors
06/18/1998CA2274524A1 Remedy for axillary osmidrosis containing adrenocorticosteriodal preparation
06/18/1998CA2274111A1 Transdermal preparation containing serotonin receptor antagonist
06/18/1998CA2274029A1 Fibrinogen receptor antagonists
06/18/1998CA2273988A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
06/18/1998CA2272952A1 Seco precursors of cyclopropylindolines and their use as prodrugs
06/18/1998CA2272090A1 Integrin antagonists
06/18/1998CA2272089A1 17.alpha.-dihydroequilenin for use as a medical antioxidant
06/18/1998CA2272087A1 Use of equilenin as an antioxidant
06/18/1998CA2272074A1 Use of 17.beta.-dihydroequilenin as an antioxidant
1 ... 6640 6641 6642 6643 6644 6645 6646 6647 6648 6649 6650 6651 6652 6653 6654 6655 6656 6657 6658 6659 6660 ... 7860